ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Aptuit plans to invest $100 million in expanding capacity, improving efficiencies, and aligning its various operations. The move follows the acquisition of EaglePicher's pharmaceutical services unit, which added two plants for making active pharmaceutical ingredients, and the West Lafayette, Ind.-based solid-state chemistry specialist SSCI. Aptuit, which was founded in 2004 as a drug development firm, says the investment will enable better integration of its broad array of operations and services.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter